NASDAQ: NVAX
Novavax Inc Stock Ownership - Who owns Novavax?

Insider buying vs selling

Have Novavax Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Patrick KellyEVP CFO and Treasurer2026-03-075,904$9.98
$58.92kSell
Elaine OharaEVP Chief Strategy Officer2026-03-0322,429$9.49
$212.85kSell
Mark J. CaseyEVP Chief Legal Officer2026-03-0311,378$9.49
$107.98kSell
Ruxandra DraghiaakliEVP Research Development2026-03-0311,313$9.49
$107.36kSell
Ruxandra DraghiaakliEVP Research Development2026-03-0311,313$9.49
$107.36kSell
John C. JacobsPresident and CEO2026-03-0369,288$9.49
$657.54kSell
James Patrick KellyEVP CFO and Treasurer2026-03-0320,850$9.49
$197.87kSell
Elaine OharaEVP Chief Strategy Officer2026-03-0110,969$10.14
$111.23kSell
John C. JacobsPresident and CEO2026-03-0138,450$10.14
$389.88kSell
John C. JacobsPresident and CEO2026-03-0138,450$10.14
$389.88kSell

1 of 2

NVAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVAX insiders and whales buy or sell their stock.

NVAX Shareholders

What type of owners hold Novavax Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.49%15,470,365$148.82MInstitution
Shah Capital Management8.94%14,558,780$140.06MInstitution
Blackrock Inc7.92%12,901,549$124.11MInstitution
State Street Corp5.85%9,523,646$91.62MInstitution
Cadila Pharmaceuticals Ltd5.83%9,500,000$91.39MInsider
Bank Of America Corp5.09%8,290,665$79.76MInstitution
Sanofi4.22%6,880,481$66.19MInstitution
James B. 1. Tananbaum3.85%6,268,455$60.30MInsider
D E Shaw Co Inc3.68%5,992,798$57.65MInstitution
Ubs Group Ag3.00%4,894,284$47.08MInstitution

1 of 3

NVAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVAX72.31%17.25%Net SellingNet Selling
VCEL91.16%8.84%Net SellingNet Selling
HRMY77.07%22.93%Net SellingNet Selling
INVA60.21%39.79%Net BuyingNet Selling
AMLX66.79%33.21%Net SellingNet Selling

Novavax Stock Ownership FAQ

Who owns Novavax?

Novavax (NASDAQ: NVAX) is owned by 72.31% institutional shareholders, 17.25% Novavax insiders, and 10.44% retail investors. Cadila Pharmaceuticals Ltd is the largest individual Novavax shareholder, owning 9.50M shares representing 5.83% of the company. Cadila Pharmaceuticals Ltd's Novavax shares are currently valued at $91.39M.

If you're new to stock investing, here's how to buy Novavax stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.